SRTS
Sensus Healthcare, Inc
Nasdaq · usd
Sensus Healthcare, Inc (SRTS) trades at $2.26 (-4.24%) as of 4:10:04 PM EST on Nov 20, 2026, -21.25% over the past month. Market cap is $38.85M, with 7.2 days to cover in short interest.
Stock performance
How Sensus Healthcare, Inc (SRTS) stock has performed from one day to one year, with its 52-week range.
- 1D
- -4.24%
- 1W
- -2.80%
- 1M
- -21.25%
- YTD
- -43.22%
- 1Y
- -43.78%
- 52-wk range
- $2.14 – $5.49
Key statistics
Today's trading snapshot for SRTS: day range, open, previous close, volume and market cap.
- Day range
- $2.19 – $2.41
- Open
- $2.39
- Prev close
- $2.36
- Volume
- 122.02K
- Market cap
- $38.85M
- Shares out
- 16.46M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Sensus Healthcare, Inc: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 2.34
- P/B
- 1.10
- P/FCF
- —
- ROE
- -45.3%
- ROA
- -39.5%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 19, 2026
8-K filings
Material corporate events Sensus Healthcare, Inc has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 12, 2026
On November 12, 2026, Sensus Healthcare, Inc. announced via press release its financial results for the third quarter of 2026.
- Credit facilityJun 5, 2026
On June 2, 2026, Sensus Healthcare, Inc. (the "Company") entered into a Loan Agreement (the "Loan Agreement") with City National Bank of Florida ("CNB") pursuant to which CNB has made available to the Company a revolving credit facility providing for maximum borrowings of $15,000,000 (the "Loan"), which is evidenced by a Revolving Promissory Note, dated June 2, 2026 (the "Note"), made by the Company in favor of CNB. Pursuant to the terms of the Note, advances made under the Loan bear interest at the Secured Overnight Financing Rate plus 3% per annum and have a maturity date of June 5, 2027 unless extended by mutual agreement of the Company and CNB.
- Annual meeting resultsJun 2, 2026
Eric Sachetta and Michael J. Sardano were elected as Class II directors for a three-year term to expire in 2029. Each nominee was an incumbent director, and no other person was nominated.
- New auditor engagementJan 20, 2026
On January 13, 2026, the Audit Committee of the Company's Board of Directors simultaneously dismissed BPB as the Company's independent registered public accounting firm and approved the appointment of CRI as the Company's independent registered public accounting firm.
- Director departureNov 13, 2025
Mr. Sachetta fills a vacancy resulting from the death of William McCall.
SRTS short interest
How heavily SRTS is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 7.2
- Short interest
- 222.27K
- Avg volume
- 30.91K
As of · reported to FINRA twice monthly.
SRTS news
The latest news and headlines about Sensus Healthcare, Inc (SRTS).
- MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex StockholdersnegativeGlobeNewswire Inc.· Oct 9, 2025
- SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus StockholdersnegativeGlobeNewswire Inc.· Oct 9, 2025
- AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of StockholdersnegativeGlobeNewswire Inc.· Oct 9, 2025
- SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the FirmnegativeGlobeNewswire Inc.· Aug 31, 2025
- Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law FirmnegativeGlobeNewswire Inc.· Aug 28, 2025
Frequently asked questions
What is the Sensus Healthcare, Inc (SRTS) stock price today?
Sensus Healthcare, Inc (SRTS) is trading at $2.26 (-4.24% on the day) as of 4:10:04 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Sensus Healthcare, Inc?
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids.
What is the short interest in SRTS?
As of Oct 30, 2026, SRTS has 222.27K shares short and 7.2 days to cover.
What exchange is SRTS listed on?
Sensus Healthcare, Inc (SRTS) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Build with AI
Build an analysis of SRTS with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a SRTS analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.